Kliničke studije za ХОБП u državi Indijana
11 studija za ХОБП traži učesnike na lokacijama u državi Indijana.
Gradovi u državi Indijana
Zvanični tekst studije (na engleskom)
Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
- Velocity Clinical Research ( Site 4464), Valparaiso
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07874815A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Indiana University Health University Hospital, Indianapolis
- IU Health Ball Memorial Hospital, Inc., Muncie
Тражи се учесникФаза 2
Узраст од 40 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07759245To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research-Indianapolis, Indianapolis
Тражи се учесникФаза 2
Узраст од 40 до 85 · Оба пола · Ажурирано 28. 10. 2026. · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asha Clinical Research - Munster- Site Number : 8400115, Hammond
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- ASHA Clinical Research - Munster, LLC, Hammond
- Methodist Hospital Southlake, Merrillville
Тражи се учесникФаза 2/3
Узраст од 35 до 80 · Оба пола · Ажурирано 22. 10. 2026. · NCT07363694Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Indy Clinical Research- Site Number : 8400071, Indianapolis
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 19. 10. 2026. · NCT07190209The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- IU Health Pulmonology & Critical Care Medicine, Indianapolis
Тражи се учесникОпсервациона студија
Узраст 40 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07612878A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Evansville
- Research Site, Indianapolis
- Research Site, Indianapolis
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 9. 10. 2026. · NCT06878261Acoustic Waveform Respiratory Evaluation
- Indiana University, Indianapolis
Тражи се учесникЗдраве особе су добродошле
Узраст од 8 до 70 · Оба пола · Ажурирано 5. 10. 2026. · NCT06512064A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Valparaiso
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 2. 10. 2026. · NCT06283966A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Munster
Тражи се учесникФаза 3
Узраст од 40 до 80 · Оба пола · Ажурирано 3. 9. 2026. · NCT06883305Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.